Neuroone Medical Technologies CorpNASDAQ:NMTCNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE1.0200
- TODAY'S CHANGE (%)0.0400 (4.0816%)
- Bid / Lots0.9703/ 10
- Ask / Lots1.0600/ 35
- Open / Previous Close1.0300 / 0.9800
- Day Range
- 52 Week Range
- Volume28,483
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMTC |
|---|---|---|
| 09:41 ET | 100 | 1.03 |
| 09:54 ET | 615 | 1.0107 |
| 10:08 ET | 949 | 1.02 |
| 10:17 ET | 9812 | 1.0499 |
| 10:53 ET | 1695 | 1.015 |
| 11:24 ET | 500 | 1.03 |
| 11:44 ET | 1000 | 1.0386 |
| 11:49 ET | 100 | 1.04 |
| 12:23 ET | 200 | 1.03 |
| 12:32 ET | 401 | 1.03 |
| 01:06 ET | 968 | 1.0399 |
| 01:10 ET | 3099 | 1.03 |
| 01:37 ET | 526 | 1.01 |
| 01:39 ET | 100 | 0.99 |
| 02:00 ET | 100 | 0.99 |
| 02:04 ET | 100 | 1.03 |
| 02:20 ET | 100 | 0.99 |
| 02:24 ET | 100 | 1.03 |
| 02:40 ET | 100 | 0.99 |
| 02:44 ET | 299 | 1.03 |
| 02:58 ET | 100 | 0.99 |
| 03:00 ET | 322 | 1.02 |
| 03:16 ET | 300 | 1 |
| 03:18 ET | 100 | 1 |
| 03:20 ET | 100 | 1 |
| 03:32 ET | 200 | 1 |
| 03:43 ET | 100 | 1 |
| 03:50 ET | 919 | 0.99 |
| 03:52 ET | 914 | 0.99 |
| 03:54 ET | 100 | 0.99 |
| 03:57 ET | 100 | 0.99 |
| 03:59 ET | 1767 | 1.02 |
Sep 24, 2024
NeuroOne(R) Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference, from 9:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
9:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 10, 2024
NeuroOne(R) Announces Breakthrough Case Completed with OneRF(TM) Ablation System at the University Hospitals in Cleveland, from 9:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
9:00AM ET on Tuesday Sep 10, 2024 by Dow JonesNeuroOne(R) Announces Breakthrough Case Completed with OneRF(TM) Ablation System at the University Hospitals in Cleveland, from 9:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
9:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 5, 2024
NeuroOne(R) to Present at the H.C. Wainwright 26th Annual Global Investment Conference, from 6:23PM ET on Thursday Sep 05, 2024 by Dow Jones
6:23PM ET on Thursday Sep 05, 2024 by Dow JonesNeuroOne(R) to Present at the H.C. Wainwright 26th Annual Global Investment Conference, from 6:23PM ET on Thursday Sep 05, 2024 by Dow Jones
6:23PM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neuroone Medical Technologies Corp | 30.2M | -2.1x | --- |
Icecure Medical Ltd | 30.2M | -2.1x | --- |
Renalytix PLC | 20.4M | -0.3x | --- |
Positron Corp | 26.7M | -10.9x | --- |
Know Labs Inc | 30.2M | -1.5x | --- |
Vicarious Surgical Inc | 32.1M | -0.5x | --- |
Company Information
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
Contact Information
- Headquarters
- 7599 Anagram DrEDEN PRAIRIE, MN, United States 55344-7399
- Phone
- 952-426-1383
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Buckman
- President, Chief Executive Officer, Director
- David Rosa
- Co-Founder, Business Development Director - Medical Sales Liaison
- Mark Christianson
- Chief Financial Officer
- Ronald Mcclurg
- Chief Operating Officer
- Christopher Volker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.2M |
|---|---|
Revenue (TTM) | $4.0M |
Shares Outstanding | 30.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.91 |
EPS | $-0.49 |
Book Value | $0.26 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -308.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
